BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Navarro-Partida J, Castro-Castaneda CR, Santa Cruz-Pavlovich FJ, Aceves-Franco LA, Guy TO, Santos A. Lipid-Based Nanocarriers as Topical Drug Delivery Systems for Intraocular Diseases. Pharmaceutics 2021;13:678. [PMID: 34065059 DOI: 10.3390/pharmaceutics13050678] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Elsewedy HS, Shehata TM, Soliman WE. Shea Butter Potentiates the Anti-Bacterial Activity of Fusidic Acid Incorporated into Solid Lipid Nanoparticle. Polymers (Basel) 2022;14:2436. [PMID: 35746012 DOI: 10.3390/polym14122436] [Reference Citation Analysis]
2 Rebibo L, Frušić-Zlotkin M, Ofri R, Nassar T, Benita S. The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure. Int J Pharm 2022;:121627. [PMID: 35245638 DOI: 10.1016/j.ijpharm.2022.121627] [Reference Citation Analysis]
3 Diaz-palomera CD, Vidal-paredes IA, Navarro-partida J, Cid-hernandez M, Rosales-rivera LC, De la Rosa-bibiano R, Monroy-ramirez HC, Santos A, Armendariz-borunda J. Topical Pirfenidone-Loaded Liposomes Ophthalmic Formulation Reduces Haze Development after Corneal Alkali Burn in Mice. Pharmaceutics 2022;14:316. [DOI: 10.3390/pharmaceutics14020316] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bonilla L, Espina M, Severino P, Cano A, Ettcheto M, Camins A, García ML, Souto EB, Sánchez-López E. Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics 2021;14:90. [PMID: 35056986 DOI: 10.3390/pharmaceutics14010090] [Reference Citation Analysis]
5 Sahu DK, Pradhan D, Biswasroy P, Kar B, Ghosh G, Rath G. Recent trends in nanocarrier based approach in the management of dry eye disease. Journal of Drug Delivery Science and Technology 2021;66:102868. [DOI: 10.1016/j.jddst.2021.102868] [Reference Citation Analysis]
6 Vaneev A, Tikhomirova V, Chesnokova N, Popova E, Beznos O, Kost O, Klyachko N. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye. Int J Mol Sci 2021;22:12368. [PMID: 34830247 DOI: 10.3390/ijms222212368] [Reference Citation Analysis]
7 López-Machado A, Díaz-Garrido N, Cano A, Espina M, Badia J, Baldomà L, Calpena AC, Souto EB, García ML, Sánchez-López E. Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation. Pharmaceutics 2021;13:1698. [PMID: 34683990 DOI: 10.3390/pharmaceutics13101698] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Hosny KM, Rizg WY, Alkhalidi HM, Abualsunun WA, Bakhaidar RB, Almehmady AM, Alghaith AF, Alshehri S, El Sisi AM. Nanocubosomal based in situ gel loaded with natamycin for ocular fungal diseases: development, optimization, in-vitro, and in-vivo assessment. Drug Deliv 2021;28:1836-48. [PMID: 34515597 DOI: 10.1080/10717544.2021.1965675] [Reference Citation Analysis]